Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment

Endocrine-related Cancer
Belinda van ZylNikola A Bowden

Abstract

Ovarian cancer has poor survival rates due to a combination of diagnosis at advanced disease stages and disease recurrence as a result of platinum chemotherapy resistance. High-grade serous ovarian cancer (HGSOC), the most common ovarian cancer subtype, is conventionally treated with surgery and paclitaxel/carboplatin combination chemotherapy. Initial response rates are 60-80%, but eventually the majority of patients become platinum-resistant with subsequent relapses. Extensive research on individual biomarkers of platinum resistance has revealed many potential targets for the development new treatments. While this is ongoing, there are also epigenetic, DNA repair, genome and immune changes characterised in platinum-resistant HGSOC that can be targeted with current therapies. This review discusses biomarkers of platinum chemotherapy resistance in ovarian cancer with a focus on biomarkers that are targetable with alternative treatment combinations to those currently used. After decades of research focused on elucidating the biological cause of platinum resistance, future research needs to focus on using this knowledge to overcome resistance for patients with ovarian cancer.

References

Oct 7, 1992·Journal of the National Cancer Institute·M DabholkarE Reed
Jul 17, 1971·Lancet·M F Fathalla
Jan 5, 2002·Journal of the National Cancer Institute·John P GeislerRichard E Buller
Jan 17, 2004·Biochimie·Renata M A CostaCarlos F M Menck
Apr 17, 2004·The American Journal of Surgical Pathology·Anais MalpicaElvio G Silva
Apr 28, 2004·The American Journal of Pathology·Ie-Ming Shih, Robert J Kurman
Feb 24, 2006·Nature Reviews. Molecular Cell Biology·Jean Paul Thiery, Jonathan P Sleeman
May 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Susan H WeiKenneth P Nephew
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jacobus PfistererUNKNOWN EORTC GCG
Jan 27, 2007·The American Journal of Surgical Pathology·David W KindelbergerChristopher P Crum
Aug 2, 2007·The American Journal of Surgical Pathology·Anais MalpicaElvio G Silva
Aug 19, 2007·Nature Methods·Margaret S EbertPhillip A Sharp
Aug 21, 2007·Journal of Clinical Pathology·W G McCluggage
Oct 15, 2008·The Journal of Pathology·F PonténM Uhlen
Jan 21, 2009·Cellular and Molecular Life Sciences : CMLS·T Nouspikel
Apr 16, 2009·Journal of Ovarian Research·Cécile Le PageAnne-Marie Mes-Masson
Jun 1, 2007·Molecular Oncology·Santiago Ropero, Manel Esteller
Jun 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tanya StoyanovaPradip Raychaudhuri
Oct 13, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Shozo YoshidaHiroshi Kobayashi
Dec 17, 2009·International Journal of Cancer. Journal International Du Cancer·Bassant M BarakatAltaf A Wani
Dec 18, 2009·Expert Review of Anticancer Therapy·Philipp HarterAndreas du Bois
Dec 18, 2009·Nature·Erin D PleasanceMichael R Stratton
Feb 16, 2010·The American Journal of Surgical Pathology·Robert J Kurman, Ie-Ming Shih
Jun 10, 2010·The Journal of Biological Chemistry·Koichi WatashiKuan-Teh Jeang
Jul 22, 2010·Molecular Cancer Therapeutics·Maurizio D'Incalci, Carlos M Galmarini
Sep 3, 2010·Cancer Research·Nikola A BowdenRodney J Scott
Jan 14, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P M L H VenckenC Seynaeve
Mar 8, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P SchöffskiR Rosell
Mar 10, 2011·Nature Medicine·Hans Clevers
Mar 24, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Phong TrangFrank J Slack
Apr 12, 2011·International Journal of Cancer. Journal International Du Cancer·Ilona KryczekWeiping Zou
May 6, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gavin C E StuartUNKNOWN Gynecologic Cancer Intergroup
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jul 8, 2011·The Journal of Pathology·Paul M WilkersonJorge S Reis-Filho
Dec 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adam D StegCharles N Landen

❮ Previous
Next ❯

Citations

Oct 9, 2019·Expert Opinion on Investigational Drugs·Maryam Shariati, Funda Meric-Bernstam
Nov 23, 2019·Journal for Immunotherapy of Cancer·Yu-Li ChenWen-Fang Cheng
Dec 22, 2019·Biomolecules·Cédric RébéFrançois Ghiringhelli
Jun 11, 2019·International Journal of Oncology·Lingzhi WangZhumei Cui
Dec 24, 2018·International Journal of Molecular Sciences·Tannith M NoyeCarmela Ricciardelli
Sep 19, 2019·Metallomics : Integrated Biometal Science·Annabelle BallestaPeter J Sadler
Jan 11, 2020·Frontiers in Bioengineering and Biotechnology·S Udhaya KumarHatem Zayed
Mar 16, 2019·Cells·Miguel Angel Merlos RodrigoVojtech Adam
Oct 21, 2020·Asia-Pacific Journal of Clinical Oncology·Karen Kar Loen ChanHextan Yuen Sheung Ngan
Oct 30, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Wan-Qiong HuangWen-Xiu Ni
Jan 29, 2021·The Journal of Obstetrics and Gynaecology Research·Quan QuanXiaoling Mu
Apr 4, 2021·International Journal of Molecular Sciences·Beata SzeflerPrzemysław Krawczyk
May 1, 2021·Neoplasia : an International Journal for Oncology Research·María Ovejero-SánchezAna Belén Herrero
Jul 28, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Marta NowackaRadoslaw Januchowski
Oct 1, 2021·The Journal of International Medical Research·Jianxiu DuanShengdan Nie
Sep 16, 2020·Seminars in Cancer Biology·Olivia Le SauxS Intidhar Labidi-Galy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.